65 related articles for article (PubMed ID: 21823633)
41. The possible use of cyanogen bromide fragments in the semisynthesis of proteins and polypeptides.
Offord RE
Biochem J; 1972 Sep; 129(2):499-501. PubMed ID: 4643335
[No Abstract] [Full Text] [Related]
42. Recent advances in the synthesis of C-terminally modified peptides.
Arbour CA; Mendoza LG; Stockdill JL
Org Biomol Chem; 2020 Sep; 18(37):7253-7272. PubMed ID: 32914156
[TBL] [Abstract][Full Text] [Related]
43. Studies on peptides. XIV. Synthesis of lysyl-S-benzylcysteinylalanylglutaminyl-S-benzylcysteinylhistidine, a peptide related to horse heart cytochrome C.
Yajima H; Nishimura O; Kawasaki K; Okada Y
Chem Pharm Bull (Tokyo); 1967 Jun; 15(6):854-62. PubMed ID: 6076796
[No Abstract] [Full Text] [Related]
44. The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells.
Naresh A; Long W; Vidal GA; Wimley WC; Marrero L; Sartor CI; Tovey S; Cooke TG; Bartlett JM; Jones FE
Cancer Res; 2006 Jun; 66(12):6412-20. PubMed ID: 16778220
[TBL] [Abstract][Full Text] [Related]
45. Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions.
Finnegan NM; Curtin JF; Prevost G; Morgan B; Cotter TG
Br J Cancer; 2001 Jul; 85(1):115-21. PubMed ID: 11437412
[TBL] [Abstract][Full Text] [Related]
46. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release.
Kandasamy K; Srinivasula SM; Alnemri ES; Thompson CB; Korsmeyer SJ; Bryant JL; Srivastava RK
Cancer Res; 2003 Apr; 63(7):1712-21. PubMed ID: 12670926
[TBL] [Abstract][Full Text] [Related]
47. Postnatal brain development and neural cell differentiation modulate mitochondrial Bax and BH3 peptide-induced cytochrome c release.
Polster BM; Robertson CL; Bucci CJ; Suzuki M; Fiskum G
Cell Death Differ; 2003 Mar; 10(3):365-70. PubMed ID: 12700636
[TBL] [Abstract][Full Text] [Related]
48. Method for the affinity purification of covalently linked peptides following cyanogen bromide cleavage of proteins.
Shi T; Weerasekera R; Yan C; Reginold W; Ball H; Kislinger T; Schmitt-Ulms G
Anal Chem; 2009 Dec; 81(24):9885-95. PubMed ID: 19924875
[TBL] [Abstract][Full Text] [Related]
49. Chemical synthesis of cell-permeable apoptotic peptides from in vivo produced proteins.
Fricke T; Mart RJ; Watkins CL; Wiltshire M; Errington RJ; Smith PJ; Jones AT; Allemann RK
Bioconjug Chem; 2011 Sep; 22(9):1763-7. PubMed ID: 21823633
[TBL] [Abstract][Full Text] [Related]
50. Convergent protein synthesis.
Casi G; Hilvert D
Curr Opin Struct Biol; 2003 Oct; 13(5):589-94. PubMed ID: 14568613
[TBL] [Abstract][Full Text] [Related]
51. Cell-penetrating peptide technology to deliver chaperones and associated factors in diseases and basic research.
Dietz GP
Curr Pharm Biotechnol; 2010 Feb; 11(2):167-74. PubMed ID: 20166965
[TBL] [Abstract][Full Text] [Related]
52. Peptide ligation and its application to protein engineering.
Cotton GJ; Muir TW
Chem Biol; 1999 Sep; 6(9):R247-56. PubMed ID: 10467135
[TBL] [Abstract][Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
